Explore our comprehensive coverage of crispr therapy, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
An authoritative impact analysis revealing how the simultaneous collision of FDA CRISPR approvals, PBM GLP-1 cost hikes, and catastrophic clearinghous...
Read Full Story →![[Medical Research's October Reckoning: Five Breakthroughs Reshape Therapeutics, Pricing, and Patient Access]](https://www.crimaz.com/assets/images/no-image.png)
Medical Research[Five October 2026 medical breakthroughs—retatrutide approval, Alzheimer's blood test coverage, CR...
HealthcareThe simultaneous federal probe into AI-driven prior authorization, the FDA's approval of a $2.8M CRI...
HealthcareThe convergence of CMS Medicare Advantage rate restructuring, FDA CRISPR approvals, PBM merger block...
Medical Research[The simultaneous FDA approvals of a triple-agonist for MASH, in vivo CRISPR for hypercholesterolemi...
